Keros Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
LEXINGTON, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on […]